UOC
UBS O'Connor Portfolio holdings
AUM
$1.93B
1-Year Return
38.75%
This Quarter Return
+7.72%
1 Year Return
+38.75%
3 Year Return
+182.42%
5 Year Return
+480.25%
10 Year Return
+1,573.29%
AUM
$4.73B
AUM Growth
+$538M
(+13%)
Cap. Flow
+$103M
Cap. Flow
% of AUM
2.17%
Top 10 Holdings %
Top 10 Hldgs %
48.18%
Holding
712
New
102
Increased
142
Reduced
245
Closed
144
Top Buys
| 1 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$245M |
| 2 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
+$230M |
| 3 |
PDCE
PDC Energy, Inc.
PDCE
|
+$221M |
| 4 |
SYNH
Syneos Health, Inc. Class A Common Stock
SYNH
|
+$141M |
| 5 |
LSI
Life Storage, Inc.
LSI
|
+$87.5M |
Top Sells
| 1 |
First Horizon
FHN
|
+$179M |
| 2 |
AQUA
Evoqua Water Technologies Corp. Common Stock
AQUA
|
+$146M |
| 3 |
PRVB
Provention Bio, Inc. Common Stock
PRVB
|
+$70.5M |
| 4 |
Tower Semiconductor
TSEM
|
+$46.1M |
| 5 |
XM
Qualtrics International Inc. Class A Common Stock
XM
|
+$45.3M |
Sector Composition
| 1 | Healthcare | 32.5% |
| 2 | Technology | 15.54% |
| 3 | Financials | 12.09% |
| 4 | Real Estate | 8.52% |
| 5 | Materials | 5.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
326
Zura Bio
ZURA
$144M
| $1.37M | 0.03% |
+167,167
| New | +$1.37M |
|
327
InflaRx
IFRX
$107M
| $1.36M | 0.03% |
+305,000
| New | +$1.36M |
|
328
Zoom
ZM
$25.5B
| $1.36M | 0.03% |
20,000
+5,000
| +33% | +$339K |
|
|
VZIO
329
DELISTED
VIZIO Holding Corp.
VZIO
| $1.35M | 0.03% |
+200,000
| New | +$1.35M |
|
330
Adaptive Biotechnologies
ADPT
$1.91B
| $1.34M | 0.03% |
199,840
+21,254
| +12% | +$143K |
|
331
PSQ Holdings
PSQH
$78.1M
| $1.33M | 0.03% |
129,285
-343,336
| -73% | -$3.53M |
|
332
Rigel Pharmaceuticals
RIGL
$742M
| $1.32M | 0.03% |
102,677
+26,926
| +36% | +$347K |
|
333
iRhythm Technologies
IRTC
$6.01B
| $1.31M | 0.03% |
12,529
-3,186
| -20% | -$332K |
|
334
Welltower
WELL
$113B
| $1.3M | 0.03% |
16,087
-22,285
| -58% | -$1.8M |
|
335
Acrivon Therapeutics
ACRV
$56.3M
| $1.3M | 0.03% |
+100,000
| New | +$1.3M |
|
|
FUSN
336
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
| $1.28M | 0.03% |
274,568
+32,542
| +13% | +$152K |
|
337
Savara
SVRA
$665M
| $1.28M | 0.03% |
400,352
-156,161
| -28% | -$499K |
|
|
AUTL
338
Autolus Therapeutics
AUTL
$381M
| $1.26M | 0.03% |
530,919
-226,089
| -30% | -$538K |
|
|
JAQC
339
DELISTED
Jupiter Acquisition Corporation Common stock
JAQC
| $1.23M | 0.03% |
120,173
-352,449
| -75% | -$3.62M |
|
340
Cameco
CCJ
$33.6B
| $1.23M | 0.03% |
+39,300
| New | +$1.23M |
|
341
Orthofix Medical
OFIX
$581M
| $1.23M | 0.03% |
68,032
+3,352
| +5% | +$60.5K |
|
|
TRIS
342
DELISTED
Tristar Acquisition I Corp.
TRIS
| $1.22M | 0.03% |
116,910
-2,635
| -2% | -$27.6K |
|
343
Relay Therapeutics
RLAY
$700M
| $1.21M | 0.03% |
96,385
+52,285
| +119% | +$657K |
|
344
BioAtla
BCAB
$35.9M
| $1.21M | 0.03% |
402,722
+157,697
| +64% | +$473K |
|
345
Strategy Inc Common Stock Class A
MSTR
$93.5B
| $1.2M | 0.03% |
+35,050
| New | +$1.2M |
|
346
Guidewire Software
GWRE
$22B
| $1.14M | 0.02% |
15,000
-87,500
| -85% | -$6.66M |
|
347
SCYNEXIS
SCYX
$38.4M
| $1.14M | 0.02% |
386,019
-199,651
| -34% | -$589K |
|
348
Larimar Therapeutics
LRMR
$336M
| $1.14M | 0.02% |
363,505
+151,011
| +71% | +$473K |
|
|
THRX
349
DELISTED
Theseus Pharmaceuticals, Inc. Common Stock
THRX
| $1.13M | 0.02% |
121,452
+10,737
| +10% | +$100K |
|
350
Verastem
VSTM
$630M
| $1.12M | 0.02% |
150,904
+103,677
| +220% | +$771K |
|